Reduced glutamate neurotransmission with Alzheimer's disease -: an in vivo 13C magnetic resonance spectroscopy study
Reduced glutamate neurotransmission with Alzheimer's disease -: an in vivo 13C magnetic resonance spectroscopy study
复制标题
DOI:
10.1007/s10334-003-0004-x
复制
发表时间:
2003-02-01
影响因子:
2.3
通讯作者:
Ross, BD
中科院分区:
文献类型:
--
作者:
Lin, AP;Shic, F;Ross, BD
Cognitive impairment in Alzheimer's disease (AD) is not fully explained. PET indicates reduced cerebral metabolic rate for glucose. Since glutamate neurotransmission (GNT) consumes more than 80% of the ATP generated from metabolism, a pilot study was carried out to determine the neuronal tricarboxylic acid cycle (TCA) based on the hypothesis that reduced GNT could contribute to cognitive impairment in AD.Three AD patients with cognitive impairment (mini-mental state exam: 24 vs 30, P